While theres debate about how it works, the addition of GIP in this case may be increasing the effectiveness of GLP-1, creating an added weight loss effect
Oral antihyperglycemic therapy with a SGLT2 inhibitor reverses cognitive impairments in elderly diabetics
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
Final Thoughts Upon noticing even the slightest symptoms of UTI, see a Doctor
The phospholipid peroxidase glutathione peroxidase 4 (GPX4), a GSH-dependent lipid repair enzyme, can prevent the development of this process by eliminating lipid peroxides
That's why researchers are increasingly turning to real-world data to understand how diabetes medications perform among older adults , people with multiple conditions, and those taking several medications at once